Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Grant or award Director acquired 5,814 shares (grant or award)
  2. 4 Grant or award Director acquired 2,325,581 shares (grant or award)
  3. 4 Grant or award Director acquired 250,000 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 10,000 shares (grant or award)
  5. 4 Shares withheld for taxes Sr. VP, Chief Business Officer gave up 3,969 shares (to pay taxes)
  6. 4 Open-market buy Director bought 37,700 shares at an average $6.91 ($260,457)
  7. 4 Open-market buy President and CEO bought 10,000 shares at $7.12 ($71,200)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 4,622 shares (grant or award)
  14. 4 Grant or award Director acquired 100,000 shares (grant or award)
  15. 4 Grant or award Director acquired 3,081,664 shares (grant or award)
  16. 4 Grant or award Director acquired 770,416 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
  18. 4 Grant or award Director acquired 7,312 shares (grant or award)
  19. 4 Grant or award Director acquired 9,140 shares (grant or award)
  20. 4 Grant or award Director acquired 5,027 shares (grant or award)

Page 20 of 29 · 564 filings